Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 3077
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Vominil 10 mg/ml V/DCP/23/0023 VetViva Richter GmbH , Austrija QA04AD90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Maropitant citrate monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 27-Jun-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0023-01 1 Stikla flakons, 10 ml -
V/DCP/23/0023-02 1 Stikla flakons, 25 ml -
V/DCP/23/0023-03 1 Stikla flakons, 50 ml -
V/DCP/23/0023-04 5 Stikla flakons, 10 ml -
Alpramil mg V/DCP/22/0022 Alfasan Nederland BV, Nīderlande QP54AB51 cats Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0022-01 1 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0022-02 1 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0022-03 1 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0022-04 10 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0022-05 10 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0022-06 10 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0022-07 25 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0022-08 25 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0022-09 25 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
Alpramil mg V/DCP/22/0023 Alfasan Nederland BV, Nīderlande QP54AB51 cats Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0023-01 1 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0023-02 1 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0023-03 1 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0023-04 10 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0023-05 10 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0023-06 10 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0023-07 25 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0023-08 25 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0023-09 25 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
Milbetab 12,5 mg/125 mg - V/DCP/19/0045 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 09102025LI (09-Oct-2025)
Labelling text: [DOCX] 09102025M (09-Oct-2025)
Summary of product characteristics: [DOCX] 09102025ZA (09-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0045-01 12,5/125 mg 1 Blisteris, 2 tablete -
V/DCP/19/0045-02 12,5/125 mg 2 Blisteris, 2 tablete -
V/DCP/19/0045-03 12,5/125 mg 1 Blisteris, 4 tablete -
V/DCP/19/0045-04 12,5/125 mg 1 Blisteris, 8 tablete -
V/DCP/19/0045-05 12,5/125 mg 2 Blisteris, 4 tablete -
V/DCP/19/0045-06 12,5/125 mg 4 Blisteris, 2 tablete -
V/DCP/19/0045-07 12,5/125 mg 1 Blisteris, 10 tablete -
V/DCP/19/0045-08 12,5/125 mg 2 Blisteris, 10 tablete -
V/DCP/19/0045-09 12,5/125 mg 10 Blisteris, 2 tablete -
V/DCP/19/0045-10 12,5/125 mg 3 Blisteris, 10 tablete -
V/DCP/19/0045-11 12,5/125 mg 5 Blisteris, 10 tablete -
V/DCP/19/0045-12 12,5/125 mg 10 Blisteris, 10 tablete -
V/DCP/19/0045-13 12,5/125 mg 20 Blisteris, 10 tablete -
V/DCP/19/0045-14 12,5/125 mg 50 Blisteris, 10 tablete -
V/DCP/19/0045-15 12,5/125 mg 10 Atsevišķs iepakojums, 2 tablete -
V/DCP/19/0045-16 12,5/125 mg 10 Atsevišķs iepakojums, 20 tablete -
V/DCP/19/0045-17 12,5/125 mg 10 Atsevišķs iepakojums, 50 tablete -
Ketamidor 10% 100 mg/ml V/NRP/01/1290 VetViva Richter GmbH , Austrija QN01AX03 cattle; pigs; sheep; goats; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketamine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1290-01 100 mg/ml 1 Stikla flakons, 10 ml -
Catobevit 100 mg/ml + 0,05 mg/ml - V/DCP/19/0009 KRKA, d.d., Novo mesto, Slovēnija QA12CX99 cattle; horses; dogs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Butaphosphan, Cyanocobalamin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Apr-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0009-01 100 mg/0,05 ml 1 Stikla pudele (dzintarkrāsas), 100 ml -
V/DCP/19/0009-02 100 mg/0,05 ml 1 Stikla pudele (dzintarkrāsas), 250 ml -
Rilexine 75 mg V/NRP/07/1698 Virbac S.A., Francija QJ01DB01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Cefalexin monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1698-01 75 mg 2 Blisteris, 7 tablete [PDF]
V/NRP/07/1698-02 75 mg 30 Blisteris, 7 tablete [PDF]
Rilexine 300 mg V/NRP/07/1699 Virbac S.A., Francija QJ01DB01 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Cefalexin monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1699-01 300 mg 2 Blisteris, 7 tablete [PDF] [PDF]
V/NRP/07/1699-02 300 mg 30 Blisteris, 7 tablete [PDF] [PDF]
Rilexine 600 mg V/NRP/07/1700 Virbac S.A., Francija QJ01DB01 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Cefalexin monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1700-01 600 mg/tabl. 2 Blisteris, 7 tablete [PDF]
V/NRP/07/1700-02 600 mg/tabl. 30 Blisteris, 7 tablete [JPG] [JPG]
Firodyl 62.5 mg V/DCP/20/0002 Ceva Sante Animale', Francija QM01AH90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Firocoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CEVA SANTE ANIMALE, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0002-01 62,5 mg 12 PA/Al/PVH//Al blisteris, 12 tablete -
V/DCP/20/0002-02 62,5 mg 36 PA/Al/PVH//Al blisteris, 12 tablete -
V/DCP/20/0002-03 62,5 mg 96 PA/Al/PVH//Al blisteris, 12 tablete -
Ampiclox LC - V/NRP/99/0979 Zoetis Belgium S.A., Beļģija QJ51CR50 cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Ampicillin sodium, Cloxacillin sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija
Date of authorisation/renewal: 03-Dec-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Jun-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jun-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/99/0979-01 1 Injektors, 1 deva -
V/NRP/99/0979-02 24 Injektors, 1 deva [PDF] [PDF]
Mektix CHEWABLE 4 mg/10 mg - V/MRP/19/0031 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 small cats; kittens weighing at least 0.5 kg Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Jun-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 071122LI (27-Jul-2023)
Labelling text: [PDF] 21102019M (27-Jul-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (27-Jul-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/19/0031-01 4/10 mg 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/MRP/19/0031-02 4/10 mg 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/MRP/19/0031-03 4/10 mg 12 Al/OPA/Al/PVH blisteris, 4 tablete -
Mektix CHEWABLE 16 mg/40 mg - V/MRP/19/0032 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 cats weighing at least 2 kg Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Jun-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 071122LI (27-Jul-2023)
Labelling text: [PDF] 21102019M (27-Jul-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Jul-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/19/0032-01 16/40 mg 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/MRP/19/0032-02 16/40 mg 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/MRP/19/0032-03 16/40 mg 12 Al/OPA/Al/PVH blisteris, 4 tablete -
Tullavis 100 mg/ml V/DCP/20/0053 Industrial Veterinaria, S.A., Spānija QJ01FA94 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tulathromycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Industrial Veterinaria, S.A., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0053-01 100 mg/ml 1 Stikla flakons, 20 ml -
V/DCP/20/0053-02 100 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/20/0053-03 100 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/20/0053-04 100 mg/ml 1 Stikla flakons, 250 ml -
ZIPYRAN PLUS - V/NRP/02/1520 Laboratorios Calier, S.A., Spānija QP52AA51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Praziquantel, Pyrantel embonate, Febantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija
Date of authorisation/renewal: 13-Jun-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (14-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1520-02 1 Blisteris, 10 tablete -
V/NRP/02/1520-05 25 Blisteris, 10 tablete -
V/NRP/02/1520-06 1 Blisteris, 2 tablete -
V/NRP/02/1520-07 2 Blisteris, 10 tablete -
V/NRP/02/1520-08 10 Blisteris, 10 tablete -
Introflor Vet 300 mg/ml V/MRP/25/0069 Interchemie Werken De Adelaar Eesti AS, Igaunija QJ01BA90 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Florfenicol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 13-Nov-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/25/0069-01 1 Stikla flakons, 100 ml -
Duelmint 100 - V/NRP/08/1569 Fatro S.p.A., Itālija QP52AC59 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: paste for oral use
International name (active substance): Mebendazole,Praziquantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1569-01 1 Plastikāta tūbiņa, 15 ml -
Domosedan Vet 10 mg/ml V/MRP/02/1451 Orion Corporation, Somija QN05CM90 cattle; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Detomidine hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Orion Corporation Orion Pharma, Somija
Date of authorisation/renewal: 06-Jun-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jun-2024)
Summary of product characteristics: [DOCX] 29062020ZA (10-Jun-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/02/1451-01 10 mg/ml 1 Stikla flakons, 5 ml -
V/MRP/02/1451-02 10 mg/ml 1 Stikla flakons, 20 ml -
V/MRP/02/1451-03 10 mg/ml 6 Stikla flakons, 5 ml -
V/MRP/02/1451-04 10 mg/ml 10 Stikla flakons, 5 ml -
V/MRP/02/1451-05 10 mg/ml 5 Stikla flakons, 20 ml -
V/MRP/02/1451-06 10 mg/ml 10 Stikla flakons, 20 ml -
Alfasalix 1000 mg/g V/DCP/25/0070 Alfasan Nederland BV, Nīderlande QN02BA04 cattle (calf); pigs Vairāk

Medicinal product information

Pharmaceutical form: powder for use in drinking water
International name (active substance): Sodium salicylate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Nov-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0070-01 1 Maiss, 100 g -
V/DCP/25/0070-02 1 Maiss, 1 kg -
V/DCP/25/0070-03 1 Maiss, 5 kg -
Ototop - V/DCP/20/0030 Industrial Veterinaria, S.A., Spānija QS02CA01 guinea pigs; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: ear drops and cutaneous suspension
International name (active substance): Miconazole nitrate, Prednisolone acetate, Polymyxin B sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0030-01 1 ZBPE pudelīte, 15 ml -
V/DCP/20/0030-02 1 ZBPE pudelīte, 30 ml -
V/DCP/20/0030-03 1 ZBPE pudelīte, 100 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy